Pernix Therapeutics Holdings, Inc. (PTX) CEO John Sedor on Q3 2018 Results - Earnings Call Transcript

On the call today are John Sedor, Chairman and CEO; George Jones, Vice President of Sales … Turning to Contrave, a market-leading prescription product indicated for weight loss.